Literature DB >> 6269686

Gastric mucus secretion in ranitidine-treated patients.

M Guslandi, E Ballarin, A Tittobello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6269686      PMCID： PMC1506962          DOI： 10.1136/bmj.283.6293.699

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Carbenoxolone maintenance in cimetidine-healed patients.

Authors:  M Guslandi; M Cambielli; A Tittobello
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

2.  Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism.

Authors:  D A Henry; I A Macdonald; G Kitchingman; G D Bell; M J Langman
Journal:  Br Med J       Date:  1980-09-20

3.  Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.

Authors:  W Domschke; G Lux; S Domschke
Journal:  Gastroenterology       Date:  1980-12       Impact factor: 22.682

4.  Cimetidine and ranitidine in duodenal ulcer.

Authors:  M J Langman; D A Henry; G B Bell; W R Burnham; A Ogilvy
Journal:  Br Med J       Date:  1980-08-16
  4 in total
  5 in total

1.  Proton pump inhibitors and mucus secretion.

Authors:  Mario Guslandi
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

Review 2.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

Review 3.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 4.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.

Authors:  Chara Litou; Maria Vertzoni; Constantinos Goumas; Vassilis Vasdekis; Wei Xu; Filippos Kesisoglou; Christos Reppas
Journal:  Pharm Res       Date:  2016-03-14       Impact factor: 4.200
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.